- Filed
- Oct 26, 2026
- Pages
- 181
- Underwriters
- —
Road to listing
98 days from first draft to public filing- Draft submittedJul 20 · DRSA first draft of the registration statement, sent to the SEC in confidence.0001493152-26-033824
- Draft amendedSep 10 · DRS/A0001493152-26-042030
- Filed in publicToday · S-1The registration statement, public for the first time.0001493152-26-048438
- RoadshowNov 10 at the earliestA company that filed drafts in confidence must file in public at least 15 days before its roadshow begins.
- EffectiveNot yet · EFFECTThe SEC declares the registration statement effective, and the shares can be sold.
- PricedNot yet · 424B4The final prospectus, with the price the shares sold at.
- First tradeNot yet · LISThe shares open on the exchange, and the desk covers the company in full.
The company sent the SEC 2 drafts in confidence over 98 days, then filed in public on October 26, 2026. Its roadshow can begin November 10, 2026 at the earliest, 15 days after the public filing. The dashed stops are still to come.
Reading
Thaler Agent, each line on its passageLIS Technologies has generated no revenue and reported a net loss of $29,688,039 for the nine months ended July 31, 2026, with an accumulated deficit of $65,418,743.¶1¶2
The company estimates net proceeds of approximately $15.1 million, or approximately $17.5 million if the underwriters exercise their over-allotment option in full, at an assumed $6.00 price.¶3
In October 2026, a cylinder of UF 6 was delivered to the Oak Ridge Test Demonstration Facility, and the NRC approved the company’s Standard Practice Procedures Plan.¶4
- Net loss
- $29,688,039¶5
- Accumulated deficit
- $65,418,743 through July 31, 2026¶1
- Net cash used in operating activities
- $14,819,401 nine months ended July 31, 2026¶2
- Net proceeds to us
- $15.1 million based on assumed initial public offering price of $6.00 per share, before over-allotment¶3
- Insider purchase limit
- $250,000 each of Mr. Yu and Mr. Liebenberg indicated interest in purchasing up to¶6
- Facility investment goal
- $1.38 billion flagship commercial scale facility at K-25 site, announced January 2026¶7
Balance sheet
As filed, in the prospectus’s own lines.
| Line | Oct 31, 2024 | Oct 31, 2025 | Jul 31, 2026 |
|---|---|---|---|
| Cash | |||
| Accounts receivable | — | ||
| Prepaid expenses and other assets | — | ||
| Deferred offering costs | — | — | |
| Total current assets | |||
| Right-of-use assets | |||
| Property, plant and equipment | |||
| In-process research and development | |||
| Total assets | |||
| Accounts payable and accrued liabilities | |||
| Lease liabilities, current | |||
| Total current liabilities | |||
| Lease liabilities, non-current | |||
| Acquisition consideration payable in equity | |||
| Deferred tax liability | — | — | |
| Total liabilities | |||
| 56,575,067 and 40,058,657 shares issued and outstanding as of October 31, 2025 and 2024, respectively | — | ||
| Stock subscriptions | — | — | |
| Preferred stock | — | — | — |
| Common stock | |||
| Additional paid-in capital | |||
| Accumulated deficit | |||
| Total stockholders’ equity | |||
| Total liabilities and stockholders’ equity |
Read from the prospectus’s tables, merged into one statement: the audited financial statements first, every other table checked against them.
From SEC EDGAR · Form S-1 · 0001493152-26-048438 · filed October 26, 2026